AzTrials
AzTrials

Education of PatientsNCT03737097

Online Spaced Education to Improve Fall Prevention by Patients With Multiple Sclerosis

A study testing Online Spaced Education and Brochure Education in people with Education of Patients, run by Hospital Israelita Albert Einstein at 1 site in Brazil.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Multiple sclerosis (MS) is a chronic, progressive and neurodegenerative inflammatory disease that affects young adults. In many countries it has been described as the main cause of neurological incapacity in this age group. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Education of Patients
What is being tested?
Online Spaced Education and Brochure Education
Could I receive a placebo?
No, everyone receives an active treatment
How many people
320 participants
Where
1 siteBrazil
Study dates
21 Feb 2019to 15 Nov 2019
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Multiple sclerosis diagnosis
  • Accept to be part in the study
  • Have valid e-mail address

Who cannot join

  • Healthcare professionals;

Trial locations and contacts

1 site in 1 country.

Daniella C Chanes, MSN contact

551121514368

daniella.chanes@einstein.br

Brazil1 site, 1 recruiting
  • Sociedade Benef Israelitabras Hospital Albert Einstein

    São Paulo, São Paulo, 05652000

    Daniella C Chanes, MSN, 551121514368 ext. 74368, daniella.chanes@einstein.br

    Oscar P Santos, PhD

    Recruiting

Other trials in Brazil

About this study

Official title: Impact of Online Spaced Education on Long-term Retention of Knowledge About Fall Prevention by Patients With Multiple Sclerosis

Multiple sclerosis (MS) is a chronic, progressive and neurodegenerative inflammatory disease that affects young adults. In many countries it has been described as the main cause of neurological incapacity in this age group. Due to the neurological impairment, patients with multiple sclerosis have a high incidence of fall. According to studies, MS patients fall three times more than general population. In the present study, the question to be answered is: education of individuals with MS on fall prevention using the method of online spaced education provides better retention of knowledge than the traditional method? This is a clinical trial to compare two methods of education of MS patients for prevention of fall. First stage: Development and validation of materials. Step two: Pilot questions with MS patients. Step three: Intervention and evaluation of outcome.

Being tested
Online Spaced Education, Brochure Education
Keywords
Fall, Multiple Sclerosis
Medical subject headings
Multiple Sclerosis

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Online Spaced EducationOther

    Investigators created a set of fall prevention strategies for multiple sclerosis patients into an evidence-based form of online education, termed 'spaced education' (SE). Based upon two psychology research findings (the spacing and testing effects), spaced education has been shown in randomized trials to improve knowledge acquisition, boosts learning retention for up to two years, and durably improves changes in behavior.

  • Brochure EducationOther

    The investigators translated and validated the Minimizing Your Risk of Falls A GUIDE FOR PEOPLE WITH MS brochure developed by the National Multiple Sclerosis Society. The control cohort will receive the main education model for patients that has been used in the past few years.

Study groups in NCT03737097
Study groupRoleWhat they receive
Online Spaced EducationExperimentalThe intervention cohort will participate in an online spaced education on fall prevention education developed for patients with multiple sclerosis.
Receives: Other: Online Spaced Education
Brochure EducationActive comparatorThe control cohort will receive the fall prevention education in bolus through a Brochure developed by the National Multiple Sclerosis Society. The brochure was translated to portuguese and will be used in the study with authorization of the Society.
Receives: Other: Brochure Education

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in test scores between cohorts measured in weeks 1-24

    Test scores on fall prevention strategies tests in both cohorts will be registered and compared in weeks 1, 12 and 24

    Measured: Months 1-6

Secondary outcomes (7)
  1. Fall rate

    Number of self-reported falls registered by the patients in both cohorts will be compared in weeks 1, 12 and 24

    Measured: Months 1-6

  2. Adherence to fall prevention strategies

    The study will apply the Falls Prevention Strategies Survey in both cohorts in weeks 1, 12 and 24. It is a self-report instrument addressing protective behaviors related to fall risk among adults with multiple sclerosis (MS) (eg, monitoring MS symptoms, wearing proper footwear, modifying activities). Response options reflect the frequency with which the respondent engages in the behavior (ie, never, sometimes, regularly)

    Measured: Months 1-6

  3. Individuals satisfaction with the fall prevention education method

    Individuals will be asked to evaluate their satisfaction with the method they were signed in the study by a five-point Likert scale (very dissatisfied, dissatisfied, neutral, satisfied, very satisfied). Answers will be compared between both cohorts in weeks 12 and 24.

    Measured: Months 3-6

  4. Baseline knowledge levels of patients assessed via their initial responses to the questions

    Previous knowledge about fall prevention strategies will be evaluated in week 1 in both cohorts and compared

    Measured: Month 1

  5. Pre and post-test performances differences by age

    Patient performance will be evaluated in both cohorts and compared by age in weeks 1, 12 and 24

    Measured: Month 1-6

  6. Pre and post-test performances differences by gender

    Patient performance will be evaluated in both cohorts and compared by gender in weeks 1, 12 and 24

    Measured: Month 1-6

  7. Pre and post-test performances differences by history of falls

    Patient performance in pre and post-tests will be evaluated in both cohorts and will be compared between fallers and non-fallers in the group and between the cohorts in weeks 1, 12 and 24. We will consider fallers the individuals, in both groups, that have at least one reported fall in the past six months in the enrollment in the study.

    Measured: Months 1-6

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted9 Nov 2018
  2. Study start21 Feb 2019
  3. Primary completion15 Oct 2019 (estimated)
  4. Study completion15 Nov 2019 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Health services research
Allocation
Randomised
Intervention model
Parallel groups
Model description
Both arms will take place in the same period.
Masking
None (open label)
Enrolment
320 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03737097
Sponsor's protocol ID
HIAEfallMS
Status last verified
Oct 2018
First submitted
29 Oct 2018
Last updated
1 Mar 2019
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided: We do not plan to share IPD with other researchers

Questions about this trial

What is this clinical trial studying?

A study testing Online Spaced Education and Brochure Education in people with Education of Patients, run by Hospital Israelita Albert Einstein at 1 site in Brazil.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 1 Mar 2019. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Brazil. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Daniella C Chanes, MSN (551121514368, daniella.chanes@einstein.br), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in test scores between cohorts measured in weeks 1-24 (time frame: Months 1-6). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 1 Mar 2019.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in